Clinical determinants of a positive visual inspection after treatment with acetic acid for cervical cancer screening
Open Access
- 28 February 2014
- journal article
- research article
- Published by Wiley in BJOG: An International Journal of Obstetrics & Gynaecology
- Vol. 121 (6) , 739-746
Abstract
Objective: To examine the determinants of a positive visual inspection after acetic acid (VIA), including the relationship of testing positive for high‐risk human papillomavirus (HR‐HPV), which is the necessary cause of cervical cancer.Design: A prospective cohort study.Setting: Three clinical sites in rural China.Population: A total of 7541 women aged 25–65 years.Methods: All women underwent VIA, DNA testing, by two DNA tests performed on both clinician‐ and self‐collected specimens, and HPV E6 oncoprotein testing. Those positive by any test underwent colposcopy and four‐quadrant biopsy evaluation. A random sample of women with negative screening results also underwent colposcopy and, if colposcopic abnormalities were observed, four‐quadrant biopsy evaluation was performed. Women diagnosed with cervical intraepithelial neoplasia grade 2 (CIN2), or more severe grades (CIN2 + ), underwent treatment.Main outcome measure: Testing positive for VIA.Results: Overall, 7.6% (95% confidence interval, 95% CI, 7.0–8.2%) had a positive VIA. Women who tested positive for HPV were more likely to have a positive VIA than women who tested negative for HPV (15.0%, 95% CI 12.9–17.2% versus 6.3%, 95% CI 5.7–6.9%; P < 0.001). Older women were less likely to have a positive VIA (Ptrend < 0.001), including women with CIN2 + (Ptrend < 0.001). A logistic regression model demonstrated that diagnosis (CIN2 + versus <CIN2; odds ratio, OR, 32; 95% CI 11–100), testing HPV positive with a higher viral load (highest versus lowest; OR 4.3; 95% CI 2.5–7.4), and age (51 years and older versus <38 years; OR 0.22; 95% CI 0.17–0.30) were independent determinants of having a positive VIA. VIA was more likely to be positive for women with CIN2 + having an abnormal colposcopic impression versus women with CIN2 + regardless of colposcopic impression (71.4 versus 47.2%).Conclusions: The age of the population and method of disease ascertainment should be considered in the interpretation of any VIA performance.Keywords
This publication has 24 references indexed in Scilit:
- Visual inspection methods for cervical cancer preventionBest Practice & Research Clinical Obstetrics & Gynaecology, 2012
- Comparison of visual inspection with acetic acid and cervical cytology to detect high‐grade cervical neoplasia among HIV‐infected women in IndiaInternational Journal of Cancer, 2011
- Adequacy of visual inspection with acetic acid in women of advancing ageInternational Journal of Gynecology & Obstetrics, 2011
- Determinants of VIA (Visual Inspection of the Cervix After Acetic Acid Application) Positivity in Cervical Cancer Screening of Women in a Peri-Urban Area in Andhra Pradesh, IndiaCancer Epidemiology, Biomarkers & Prevention, 2010
- Association of HIV infection with distribution and viral load of HPV types in Kenya: a survey with 820 female sex workersBMC Infectious Diseases, 2010
- HPV Screening for Cervical Cancer in Rural IndiaNew England Journal of Medicine, 2009
- A new HPV-DNA test for cervical-cancer screening in developing regions: a cross-sectional study of clinical accuracy in rural ChinaThe Lancet Oncology, 2008
- Pooled analysis of the accuracy of five cervical cancer screening tests assessed in eleven studies in Africa and IndiaInternational Journal of Cancer, 2008
- Colposcopically directed biopsy, random cervical biopsy, and endocervical curettage in the diagnosis of cervical intraepithelial neoplasia II or worseAmerican Journal of Obstetrics and Gynecology, 2004
- Accuracy of visual screening for cervical neoplasia: Results from an IARC multicentre study in India and AfricaInternational Journal of Cancer, 2004